Retour aux projets

19205.1 PFLS-LS

Discovery & development of novel cancer immunotherapeutics

Résumé

Discovery & development of novel cancer immunotherapeutics

Textes supplémentaires

Abstract

Boosting tumor-directed immune responses by inhibiting tumor evasion mechanisms bears significant therapeutic promise. Although unprecedented clinical success has been achieved by blockade of immune checkpoint pathways, these therapies still have only partial efficacy. Our goal is to develop first-in-class neutralising monoclonal antibodies against a novel immune checkpoint regulator that we have identified, with the aim of strengthening antitumor immunity in cancer patients.

Participants

Walter Reith

Kontaktperson

walter.reith@unige.ch

Université de Genève Walter Reith Rue Michel Servet 1 1211 Genève GE CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-08-31
Date de fin
2018-02-28
Coûts totaux approuvés
CHF 332545.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%